
IBUB researchers design a drug capable of acting simultaneously against three different therapeutic targets
Study led by researchers of the Institute of Biomedicine of the University of Barcelona (IBUB) has developed a new pharmacological tool capable of simultaneously administering three oligonucleotide-based drugs, each acting against a different therapeutic target within the cell. The paper, published in the journal Bioorganic Chemistry, presents a proof-of-concept of this innovative triple-targeting compound, which








